Prostanoids but not oral therapies improveright ventricular function in pulmonary arterial hypertension

JACC: Heart Failure

Volumn 1, Issue 4, 2013, Pages 300-307

  Brittain, Evan L ^a   Pugh, Meredith E ^a   Wheeler, Lisa A ^a   Robbins, Ivan M ^a   Loyd, James E ^a   Newman, John H ^a   Austin, Eric D ^b   Hemnes, Anna R ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

Author keywords

Hemodynamics; Pulmonary arterial hypertension; Pulmonary capacitance; Right ventricle; Right ventricular function; Right ventricular stroke work index

Indexed keywords

AMBRISENTAN; AMLODIPINE; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; FUROSEMIDE; NIFEDIPINE; PROSTACYCLIN; PROSTANOID; SILDENAFIL; TADALAFIL; TREPROSTINIL;

ADULT; ARTICLE; CARDIOVASCULAR PARAMETERS; COMPARATIVE EFFECTIVENESS; DRUG EFFICACY; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART RIGHT VENTRICLE FUNCTION; HEART STROKE VOLUME; HUMAN; LUNG CAPACITY; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OXYGEN SATURATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RIGHT VENTRICULAR STROKE WORK INDEX;

ADMINISTRATION, ORAL; ADULT; ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PROSTAGLANDINS; RETROSPECTIVE STUDIES; VENTRICULAR FUNCTION, RIGHT;

EID: 84881536905     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2013.05.004     Document Type: Article

References (21)

1. Voelkel N.F., Quaife R.A., Leinwand L.A., et al. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation 2006, 114:1883-1891.
2. Humbert M., Sitbon O., Chaouat A., et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 2010, 122:156-163.
3. van de Veerdonk M.C., Kind T., Marcus J.T., et al. Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. JAm Coll Cardiol 2011, 58:2511-2519.
4. Benza R.L., Miller D.P., Gomberg-Maitland M., et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation 2010, 122:164-172.
5. Fukamachi K., McCarthy P.M., Smedira N.G., Vargo R.L., Starling R.C., Young J.B. Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion. Ann Thorac Surg 1999, 68:2181-2184.
6. La Vecchia L., Varotto L., Zanolla L., Spadaro G.L., Fontanelli A. Right ventricular function predicts transplant-free survival in idiopathic dilated cardiomyopathy. JCardiovasc Med 2006, 7:706-710.
7. Campo A., Mathai S.C., Le Pavec J., et al. Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension. Am J Respir Crit Care Med 2010, 182:252-260.
8. Mahapatra S., Nishimura R.A., Sorajja P., Cha S., McGoon M.D. Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension. JAm Coll Cardiol 2006, 47:799-803.
9. Brittain E.L., Pugh M.E., Wheeler L.A., et al. Shorter survival in familial versis idiopathic pulmonary arterial hypertension is associated with hemodynamic markers of impaired right ventricular function. Pulm Circ 2013, In press.
10. Badesch D.B., Champion H.C., Sanchez M.A., et al. Diagnosis and assessment of pulmonary arterial hypertension. JAm Coll Cardiol 2009, 54:S55-S66.
11. Rich S., Kaufmann E., Levy P.S. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. NEngl J Med 1992, 327:76-81.
12. Slaughter M.S., Pagani F.D., Rogers J.G., et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. JHeart Lung Transplant 2010, 29:S1-S39.
13. Troosters T., Gosselink R., Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J 1999, 14:270-274.
14. Hulens M., Vansant G., Claessens A.L., Lysens R., Muls E. Predictors of 6-minute walk test results in lean, obese and morbidly obese women. Scand J Med Sci Sports 2003, 13:98-105.
15. Pavlovic M., Petkovic D., Cvetkovic M., Zdjelar K., Starcevic V., Bosnic O. Study of the mechanism of prostacyclin (PgI2) action on myocardial contractility. Agents Actions Suppl 1992, 37:171-175.
16. Montalescot G., Drobinski G., Meurin P., et al. Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure. Am J Cardiol 1998, 82:749-755.
17. Reesink H.J., Marcus J.T., Tulevski I.I., et al. Reverse right ventricular remodeling after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: utility of magnetic resonance imaging to demonstrate restoration of the right ventricle. JThorac Cardiovasc Surg 2007, 133:58-64.
18. Brittain E., Hemnes A.R., Keebler M., Lawson M., Byrd B., DiSalvo T. Right ventricular plasticity and functional imaging. Pulm Circ 2012, 2:309-326.
19. Mahapatra S., Nishimura R.A., Oh J.K., McGoon M.D. The prognostic value of pulmonary vascular capacitance determined by Doppler echocardiography in patients with pulmonary arterial hypertension. JAm Soc Echocardiogr 2006, 19:1045-1050.
20. Tedford R.J., Hassoun P.M., Mathai S.C., et al. Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. Circulation 2012, 125:289-297.
21. Forfia P.R., Fisher M.R., Mathai S.C., et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med 2006, 174:1034-1041.